Valsartan indicated for cutting post-MI death risk.(Rx)
Publication: Internal Medicine News
Publication Date: 15-SEP-05
Author: Lesney, Mark S.
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
Valsartan gained a new indication from the Food and Drug Administration last month, for reducing cardiovascular death in high-risk MI patients.
The widely prescribed antihypertensive is the first angiotensin receptor blocker to gain approval for high-risk MI survivors. Specifically, the Novartis agent was indicated to reduce cardiovascular mortality "in...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
